Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Senseonics Stock Quote

Senseonics (NYSEMKT: SENS)

Price as of July 19, 2024, 4:00 p.m. ET

Senseonics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
SENS -43.86% -59.48% -16.51% -86%
S&P +21.44% +86.27% +13.24% +172%

Senseonics Company Info

Senseonics Holdings, Inc. engages in the design, development, and commercialization of an implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a glucose monitoring device which includes sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.